IPP Bureau
Sun Pharma's Winlevi available in the US
By IPP Bureau - November 01, 2021
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
.jpg "Holborn Wells and SpeedBio India forms JV to manufacture in vitro diagnostics")
Holborn Wells and SpeedBio India forms JV to manufacture in vitro diagnostics
By IPP Bureau - November 01, 2021
Both parties are expected to invest a total of US $ 1 million to establish the brand
Laurus Labs PAT at Rs 201.90 cr. in Q2FY21
By IPP Bureau - October 29, 2021
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22
By IPP Bureau - October 29, 2021
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
NH TherAguix releases new batch for AGuIX
By IPP Bureau - October 29, 2021
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
Merck expands capacity for Antibody Drug Conjugate (ADC), therapies
By IPP Bureau - October 29, 2021
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
Takeda to acquire GammaDelta Therapeutics
By IPP Bureau - October 29, 2021
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Solve.Care and AliveCor partner to connect KardiaMobile users with physicians
By IPP Bureau - October 29, 2021
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
Mandaviya launches the sixth edition of National Formulary of India (NFI)
By IPP Bureau - October 29, 2021
The NFI is published to promote the rational use of medicines in the country.
3M Health Care and Thermo Fisher to increase efficiency in therapeutic manufacturing
By IPP Bureau - October 29, 2021
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Finvasia acquires Gini Health as it moves into healthcare tech
By IPP Bureau - October 29, 2021
Gini Health works in the domain of personalised healthcare
Boehringer Ingelheim announces EMA marketing authorisation for spesolimab
By IPP Bureau - October 29, 2021
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke
By IPP Bureau - October 29, 2021
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
Indian Pharma Market witnesses rise in volumes and prices in September.
By IPP Bureau - October 28, 2021
Acute therapies continue to report strong growth compared to chronic ones.
KIMS Hospitals to acquire 51.07 % stake in Sunshine Hospitals
By IPP Bureau - October 28, 2021
The combined entity will have 12 hospitals with 3,666 beds
